Related Experiment Video

Updated: Aug 30, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

[Erythrocyte enzymes in chronic kidney failure]

M Khlebarova, B Dishlianova, N Belovezhdov

    Vutreshni Bolesti
    |January 1, 1985
    PubMed

    Insights

    Enzyme activity in red blood cells, including glucose-6-phosphate dehydrogenase (G6PD) and pyruvate kinase (PK), increases with chronic renal insufficiency (CRI). This suggests a metabolic adaptation to kidney disease.

    Area of Science:

    • Biochemistry
    • Hematology
    • Nephrology

    Background:

    • Chronic renal insufficiency (CRI) affects numerous physiological processes.
    • Erythrocyte metabolic pathways may be altered in patients with CRI.

    Purpose of the Study:

    • To investigate the activity of key erythrocyte enzymes in patients with varying degrees of CRI.
    • To determine if enzyme activity correlates with the severity of renal insufficiency.

    Main Methods:

    • Studied 44 patients with different levels of CRI.
    • Assessed the activity of erythrocyte glucose-6-phosphate dehydrogenase (G6PD), 6-phosphogluconate dehydrogenase (6-PGD), and pyruvate kinase (PK).

    Main Results:

    • Erythrocyte enzyme activity, specifically G6PD and PK, increased with the progression of CRI.
    • The pentose phosphate pathway (PPhP) enzymes also showed increased activity.

    Conclusions:

    • Erythrocyte enzyme activity, particularly G6PD and PK, is elevated in patients with chronic renal insufficiency.
    • These findings suggest a potential metabolic adaptation in erythrocytes in response to declining kidney function.

    More Related Videos

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

    Published on: April 4, 2025

    Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells06:23

    Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

    Published on: November 21, 2025

    Related Concept Videos

    Erythropoiesis01:14

    Erythropoiesis

    Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
    Lifecycle of Erythrocytes01:22

    Lifecycle of Erythrocytes

    Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
    The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
    Factors Affecting Erythropoiesis01:24

    Factors Affecting Erythropoiesis

    The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
    Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
    EPO then...
    Dialysis01:27

    Dialysis

    Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
    Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
    Acute Kidney Injury V: Interprofessional Care01:20

    Acute Kidney Injury V: Interprofessional Care

    Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...